We identified 58 (44. 2%) patients with ureteral stricture and 73 (55. 8%) patients with ureteral leak. == Kidney transplant recipients with percutaneous ureteral interventions for ureteral complications do not have a significant difference in graft and patient survival results. Therefore , extreme nonoperative management can be confidently pursued in the appropriate clinical setting. Urological complications are a major supply of morbidity after renal transplantation. The most common postoperative complication is ureteral stricture at the ureterovesical anastomosis, with reported incidence rates up to 10%. 1-9Strictures often lead to hydronephrosis and risk Bulleyaconi cine A permanent damage to the renal allograft. Other postoperative urologic complications include ureteral leaks that commonly occur at the surgical anastomosis or less often the renal collecting system, with incidence rates up to 5. 4%. 8, 1012Leaks may occur due to ischemia, may be associated with concurrent or and subsequent stricture, technical failings, and can lead to infection if not adequately treated. These complications may also be associated with urolithiasis. 8Risk factors, such as male recipient and older donor, have been identified as Bulleyaconi cine A associated with postoperative stricture, 13and kidney graft artery multiplicity has also been associated with postoperative urological complications. 11Open-surgery techniques have been used for the correction of postoperative urological complications; however , these procedures have been associated with higher morbidity, delayed convalescence, and Rabbit Polyclonal to OR2B2 may be technically challenging. 1, 7 This concern has been addressed through the use of percutaneous nephrostomy tubes (PNT) and endourological procedures to manage these complications, both of which have exhibited favorable results and become primary interventions at many organizations. 1, 7, 1418Though there is a demonstrated success in treatment of ureteral strictures and leaks with percutaneous ureteral interventions, literature remains sparse regarding long-term transplant outcomes. In this single-center retrospective study, we examine long-term graft and patient survival outcomes in transplant recipients with previous percutaneous management of ureteral complications. == MATERIALS AND METHODS == == Patient Population == We queried the electronic health records of the University of Michigan Hospital and identified 1753 adult kidney transplant recipients between January 2000 and December 2008. Using the EMERSE search program developed at the University of Michigan, we used specific terms to identify transplant recipients who required PNT placement within 6 months of transplant, and those with additional interventions including nephroureteral stenting (NUS) and balloon dilation therapy. Indications intended for stenting included ureteral stricture and ureteral leak. At our institution, we used The Lich Gregoir extravesical ureteral tunneling technique for the transplant ureterovesical anastomosis. Clinically suspected postoperative ureteral stricture and ureteral Bulleyaconi cine A leak were confirmed by percutaneous nephrostomy with placement of PNT. Strictures were determined by luminal obstruction on antegrade/retrograde ureterography or computed tomography scan, associated with transplant kidney hydronephrosis and progressive serum creatinine elevation. The decision to put NUS Bulleyaconi cine A or augment with balloon dilation therapy was operator-dependent, with goal of completing therapy within three or more to 6 months; however , interventions remained in place until the stricture or leak resolved, even if greater than the 6-month goal. Ureteral dilation was performed by Interventional Radiology with antegrade Amplatz balloon dilators or Koon Rigid Dilators to greater than 10 French (Fr) diameter. After treatment, 8. Bulleyaconi cine A 5 Fr NUS was placed, and reevaluated every 4 weeks with repeated treatment (restenting). Patency was determined by antegrade pyelogram and/or by computed tomography with contrast, with initial PNT placement and after NUS changes. Those who failed percutaneous management (determined by the clinical evaluation of the team based on failing of improvement or intensity of the complications radiologically) went through surgical treatment unless normally contraindicated. Surgery included were ureteroneocystostomy, vesicopylostomy, or ureterourterotomy. == Statistical Analysis == Graft and patient success were confirmed for all hair transplant recipients. Graft failure was defined as graft removal, go back to dialysis or death. 19Follow-up began during transplant and ended in the occurrence on the event appealing, loss to follow-up, and also the end on the observation period, December 35, 2010. Graft and affected person survival analysis was performed using Kaplan Meier evaluation. Comparison of success curves between patient groupings was performed using the Sign rank check. In our multivariate analyses, donor, recipient, and transplant-specific factors known to be connected with graft and patient final result were from the Clinical Registry of Transplant Receivers. Donor factors included time, sex, ethnicity, weight, reason behind death, diabetes, hypertension, kidney pumped, creatinine greater than 1 . 3, heart stroke, and broadened criteria donor. Recipient factors included making love, ethnicity, insurance type,.